GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, OPRK1, OPRM1, PDE3A, PDE3B, SRC, TYR |
8.94982 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
8.21285 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC, TYR |
8.21285 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, HSD11B2, OPRK1, OPRM1, PDE3A, SRC, TYR |
8.21285 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
7.78426 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, KDR, MET, MIF, OPRD1, OPRK1, OPRM1, PDE3A, SRC, TNKS, TNKS2, XDH |
7.75194 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP4, FLT3, HSD11B2, HSD17B2, HTR2A, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC, TYR |
7.57692 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FLT3, HSD11B2, HSD17B2, OPRK1, OPRM1, SRC, TYR |
7.42 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, ESR1, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, MIF, PDE3A |
7.22054 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
7.09032 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
7.09032 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.75918 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SRC, TNKS, TNKS2, TYR, XDH |
6.60793 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, F3, FLT3, HTR1A, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, OPRM1, PIM1, SRC, XDH |
6.45489 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FLT3, HSD11B2, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
6.33929 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, PTPN1, SRC, TNKS, TNKS2, XDH |
6.2695 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CDK6, DRD1, DRD2, HTR2A, KDR, MIF, OPRK1, SRC, TNKS, TNKS2 |
6.2695 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, SRC, TNKS2, TYR |
6.2695 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, ESR1, F3, FLT3, HTR1A, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1 |
6.2695 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.23258 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FUT7, GBA2, MIF, PDE10A, PDE3A, PDE3B, PIM1, TYR, XDH |
6.18055 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, OPRK1 |
5.95164 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, TNKS, TNKS2, XDH |
5.93345 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
5.8669 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, TNKS, TNKS2, XDH |
5.82959 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
5.82959 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.82522 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, HSD11B2, HTR2A, KDR, OPRK1, OPRM1, PDE3A, SRC |
5.80062 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, HTR2A, KDR, MET, MIF, MMP2, MMP9, PDE3A, PDE3B, PIM1, SIGMAR1, SRC, TNKS2, TYR |
5.68826 |
[BP] GO:0038003 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.30675 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, PTPN1, SRC, TNKS, TNKS2, XDH |
5.27406 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, KDR, OPRD1, OPRK1, SRC |
5.27406 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, F3, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, XDH |
5.13433 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MIF, MMP1, MMP2, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SRC, TNKS, TNKS2, TYR, XDH |
5.11787 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FLT3, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
5.11787 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, ESR1, HTR2A, OPRD1, OPRK1, OPRM1 |
5.07674 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, AXL, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SIGMAR1, SRC, TNKS, TNKS2 |
4.99468 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FLT3, HSD11B2, OPRK1, PDE3B, SRC |
4.79143 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MIF, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PTPN1, SRC |
4.76846 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
4.73549 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.62889 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GBA2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SRC, TNKS, TNKS2, TYR, XDH |
4.57175 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP4, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, PTPN1, SRC, TNKS, TNKS2, XDH |
4.52871 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.5194 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, SRC, XDH |
4.51329 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESRRA, F3, FABP4, FLT3, HTR2A, KDR, MET, MIF, MMP12, MMP2, MMP9, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
4.51329 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PTPN1, SIGMAR1, SRC, XDH |
4.49633 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA3, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, F3, FABP4, FLT3, HSD11B2, HSD17B2, HTR1A, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PTPN1, SRC, TYR |
4.46817 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DRD2, F3, FLT3, HTR2A, KDR, MET, MIF, OPRK1, OPRM1, PTPN1, SRC, XDH |
4.36325 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, GBA2, HTR1A, TYR |
4.33243 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.31894 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, TNKS, TNKS2, XDH |
4.2593 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA3, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC |
4.24809 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, DRD1, DRD2, ESR1, ESR2, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE3B, PTPN1, SRC, XDH |
4.24809 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, DRD1, DRD2, ESR1, ESR2, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE3B, PTPN1, SRC, XDH |
4.2339 |
[BP] GO:0007193 |
None
|
DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
4.17793 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MIF, MMP9, OPRK1, SRC |
4.15093 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.12728 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A, TYR |
4.12728 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SRC, TNKS, XDH |
4.11291 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SRC, TNKS, TNKS2, TYR, XDH |
4.07451 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PTPN1, SIGMAR1, SRC, XDH |
4.07438 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, SRC, TYR |
4.05135 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SRC, TNKS, TNKS2, TYR, XDH |
4.01486 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
3.98995 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MIF, MMP9, PDE3A, PIM1, PTPN1, SIGMAR1, SRC, XDH |
3.98995 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, OPRK1, OPRM1, PDE3A, SRC |
3.96924 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, ESR1, HTR7, OPRK1, OPRM1, SRC |
3.91469 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, HTR2A, KDR, SRC |
3.89579 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A, OPRK1 |
3.86395 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.86025 |
[BP] GO:0032845 |
None
|
BCL2, DRD2, HTR2A, MIF, SRC, TNKS, TNKS2 |
3.85978 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SRC, TNKS, XDH |
3.85001 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
BCL2, CDC25B, DRD1, DRD2, ESRRB, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.82664 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
BCL2, CDC25B, DRD1, DRD2, ESRRB, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.82664 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, FABP4, FUT7, GBA2, MET, MIF, PDE3A |
3.8257 |
[BP] GO:0072523 |
None
|
AOX1, PDE10A, PDE3A, PDE3B, XDH |
3.78643 |
[BP] GO:0043269 |
regulation of ion transport
|
BCL2, CA2, CA7, DRD1, DRD2, HTR1A, HTR2A, MIF, MMP9, OPRD1, OPRK1, OPRM1 |
3.71659 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
BCL2, CDC25B, DRD2, ESRRB, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.70335 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
3.69827 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, SRC, TNKS2, XDH |
3.69732 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF |
3.69732 |
[BP] GO:0007188 |
None
|
DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
3.68164 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, HSD11B2, HTR2A, MMP2, OPRD1, OPRK1, OPRM1, SRC, TYR |
3.64879 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PTPN1, SRC |
3.64879 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, ESR2, F3, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, TNKS, TNKS2, XDH |
3.64879 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.60887 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, ESR1, IGF1R, MET, MIF, MMP9, PDE3B, PTPN1, SRC, XDH |
3.60096 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CDK6, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, OPRK1, PDE3A, PDE3B, SRC |
3.58455 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, ESR1, FABP4, IGF1R, MET, MMP9, OPRM1, PIM1, PTPN1, SRC, TNKS |
3.56452 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP4, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, PTPN1, SRC, TNKS, TNKS2, XDH |
3.55862 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF |
3.55831 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, FLT3, HSD11B2, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, SRC, TYR |
3.5551 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.53787 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PDE3A |
3.50058 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.49443 |
[BP] GO:0042325 |
regulation of phosphorylation
|
BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.46772 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, MET, MIF, PIM1, SRC, TYR |
3.46772 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, MMP9, PIM1, SIGMAR1, SRC, TYR |
3.35482 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.34002 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
3.33809 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, HTR1A |
3.32257 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, OPRM1, PDE3A, SRC |
3.32026 |
[BP] GO:0007187 |
None
|
DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
3.31337 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
BCL2, CDC25B, DRD2, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.30417 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
AURKB, BCL2, CDC25B, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
3.29205 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PTPN1, SRC |
3.28731 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, FLT3, HSD11B2, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, SRC, TYR |
3.26122 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
3.20955 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PDE3A |
3.18334 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.16934 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.16934 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.15697 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA3, CA2, DRD1, DRD2, ESR1, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, SIGMAR1, SRC |
3.12293 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, DRD1, KDR, OPRM1, SRC |
3.12293 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MIF, MMP9, PDE3A, PIM1, PTPN1, SRC |
3.10573 |
[BP] GO:0030534 |
None
|
DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1 |
2.9402 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
DRD2, FLT3, HTR2A, KDR, MIF, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.92955 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.83947 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, BCL2, CA2, CYP1B1, DRD2, ESRRB, F3, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRM1, PDE3A, PIM1, SRC |
2.82411 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2 |
2.82411 |
[BP] GO:0031635 |
None
|
OPRK1, OPRM1 |
2.82411 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.82411 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, TNKS, TNKS2 |
2.81354 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, HTR2A, MET, OPRK1 |
2.76721 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.76721 |
[BP] GO:0006198 |
None
|
PDE10A, PDE3A, PDE3B |
2.76721 |
[BP] GO:0006195 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.7578 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.74515 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF |
2.73978 |
[BP] GO:0003018 |
None
|
DRD1, HTR1A, HTR2A, HTR7, PDE3A, SRC |
2.73978 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.70995 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MIF |
2.68858 |
[BP] GO:0007631 |
None
|
DRD1, DRD2, OPRD1, OPRK1, OPRM1 |
2.66338 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTPN1, SRC |
2.66338 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.61154 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR2A, HTR7 |
2.59709 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
BCL2, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.58264 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, F3, FABP4, FLT3, HTR2A, IGF1R, MET, MIF, MMP9, OPRD1, OPRM1, PIM1, PTPN1, SRC, TNKS, XDH |
2.57452 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.54676 |
[BP] GO:0009214 |
None
|
PDE10A, PDE3A, PDE3B |
2.54676 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.49483 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, OPRD1, SRC |
2.49483 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.49155 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
DRD2, FLT3, HTR2A, IGF1R, KDR, MIF, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.48842 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, SRC |
2.48823 |
[BP] GO:0010564 |
regulation of cell cycle process
|
AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, MIF, PDE3A, SENP6, TNKS |
2.48745 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.48637 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
BCL2, CDK6, CYP19A1, DRD1, DRD2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PDE3B, PTPN1, SRC, XDH |
2.47831 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA3, AKR1B1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SIGMAR1, SRC, TNKS, TNKS2, XDH |
2.47803 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.46313 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, OPRM1 |
2.45115 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.45115 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.45115 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, PDE3A, SRC |
2.45115 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.45115 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.45115 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.45115 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, OPRD1, SRC |
2.45115 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, HTR1A, HTR2A, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC |
2.44605 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.44605 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CDC25B, CDK6, CYP1A1, DRD1, DRD2, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, KDR, MET, MIF, MMP2, MMP9, PDE3A, SRC |
2.42473 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, SENP6, SRC, TNKS |
2.42452 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, OPRK1, SRC |
2.39885 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
DRD2, HTR2A, KDR, MIF, OPRM1, PTPN1, SRC |
2.39377 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.38977 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, OPRK1, OPRM1, SRC |
2.36967 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
BCL2, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.36813 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.35877 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP4, GBA2, PDE10A, PDE3A, PDE3B, SRC, XDH |
2.35491 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.33941 |
[BP] GO:0032094 |
None
|
CYP1A1, HSD11B2, OPRM1 |
2.33781 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.33781 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
BCL2, CDC25B, DRD2, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.33781 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.33627 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, DRD1, DRD2, HTR2A, MET |
2.31456 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.31115 |
[BP] GO:1901575 |
None
|
ACHE, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP4, FUT7, GBA2, PDE10A, PDE3A, PDE3B, XDH |
2.31098 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, HTR2A, IGF1R, MIF, MMP9, OPRM1, PTPN1, SRC, TNKS, XDH |
2.30421 |
[BP] GO:0003008 |
None
|
AKR1B1, BCL2, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE3A, SRC, TYR |
2.30238 |
[BP] GO:0042698 |
ovulation cycle
|
AXL, OPRK1, OPRM1 |
2.29437 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.29437 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, OPRD1 |
2.29437 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
DRD2, HTR2A, KDR, MIF, OPRM1, SRC |
2.29019 |
[BP] GO:0044093 |
positive regulation of molecular function
|
AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, HTR2A, MET, MIF, MMP9, OPRD1, PTPN1, SRC, TNKS, XDH |
2.28546 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.28546 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, OPRD1, SRC |
2.27708 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.27122 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.27122 |
[BP] GO:0009166 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.2563 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.2538 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, KDR, MET, MIF, MMP12, OPRM1 |
2.25162 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, OPRK1, OPRM1, SRC |
2.24275 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, DRD1, DRD2, HTR2A |
2.24181 |
[BP] GO:0051881 |
regulation of mitochondrial membrane potential
|
BCL2, KDR, OPRD1, SRC |
2.24181 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.24181 |
[BP] GO:0007198 |
None
|
HTR1A, HTR7 |
2.24181 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.24181 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.24181 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.24181 |
[BP] GO:0031399 |
regulation of protein modification process
|
BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.23767 |
[BP] GO:0099536 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.23545 |
[BP] GO:0099537 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.23545 |
[BP] GO:0003013 |
None
|
DRD1, HTR1A, HTR2A, HTR7, PDE3A, SRC |
2.23545 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.23335 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR7 |
2.23335 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR7 |
2.23335 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.23335 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PDE3B, PIM1, PTPN1, SRC, TNKS, TNKS2, XDH |
2.21601 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, ESR1, ESR2, ESRRA, FABP4, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRM1, PDE3B, PTPN1, SRC, TNKS, TNKS2, XDH |
2.20455 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, SRC |
2.18957 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, F3, MET, SRC, XDH |
2.18701 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2 |
2.17369 |
[BP] GO:1901292 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.15198 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SIGMAR1, SRC, TNKS, TNKS2, TYR, XDH |
2.15001 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.14234 |
[BP] GO:0080134 |
regulation of response to stress
|
CDK6, CYP19A1, DRD2, ESR1, F3, FABP4, IGF1R, MET, MIF, MMP12, MMP2, OPRK1, PTPN1, SRC, XDH |
2.12173 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, CYP19A1, DRD2, HTR1A, HTR2A, MIF, MMP12, OPRK1, OPRM1, SRC |
2.1161 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.11493 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, DRD1, ESR1, FLT3, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.11493 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, HSD11B2, SRC |
2.11493 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.10435 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 |
2.102 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, HSD11B2, OPRM1, SRC, TYR |
2.0943 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.0814 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.0814 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.0814 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.0814 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.0814 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.0814 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, FUT7, KDR, MIF, MMP1, MMP12, MMP9, SRC |
2.08075 |
[BP] GO:0042755 |
None
|
OPRD1, OPRK1, OPRM1 |
2.07517 |
[BP] GO:0014059 |
None
|
DRD2, HTR2A, OPRK1 |
2.07517 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.04323 |
[BP] GO:0050793 |
regulation of developmental process
|
AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, HTR2A, KDR, MIF, OPRM1, PDE3A, PDE3B, PIM1, SRC, TNKS2, XDH |
2.04062 |
[BP] GO:0042310 |
None
|
HTR1A, HTR2A, HTR7 |
2.03308 |
[BP] GO:0051952 |
None
|
DRD1, DRD2, HTR2A, OPRK1 |
2.02816 |
[BP] GO:0051726 |
regulation of cell cycle
|
AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, MIF, PDE3A, PIM1, SENP6, SRC, TNKS |
2.00689 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA3, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MMP2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3B, PIM1, PTPN1, SIGMAR1, SRC, TNKS, TNKS2, TYR |
3.50442 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, AXL, CA4, DRD1, DRD2, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.05949 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA3, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PTPN1, SIGMAR1, SRC, TYR |
2.60624 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2A, KDR, MIF, MMP2, MMP9, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SIGMAR1, SRC, TNKS, TNKS2, TYR, XDH |
2.45115 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, SIGMAR1 |
2.28371 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, AXL, DRD1, DRD2, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
2.25648 |
[CC] GO:0005783 |
None
|
BCL2, CA4, CYP19A1, CYP2D6, FLT3, GBA2, KDR, OPRM1, PDE3B, PTPN1, SIGMAR1, XDH |
2.22952 |
[CC] GO:0031253 |
None
|
CA4, CA9, DRD1, DRD2, OPRD1, OPRM1, SRC |
2.1244 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1, SIGMAR1 |
2.1244 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, TNKS, TYR, XDH |
11.1585 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.57092 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SRC, TNKS, TNKS2, TYR, XDH |
9.38352 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SRC, TNKS, TNKS2, TYR, XDH |
8.94982 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, HTR1A, HTR2A, HTR7, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, TNKS, TNKS2, TYR, XDH |
7.09032 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.23258 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.40679 |
[MF] GO:0004985 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.30675 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PTPN1, TNKS |
5.27406 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.17791 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.09197 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.08571 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.05131 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.97454 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, AXL, CDK6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
4.76846 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, XDH |
4.57175 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
4.36664 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, FLT3, HTR2A, IGF1R, KDR, MET, PDE10A, PIM1, SIGMAR1, SRC |
4.3224 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR2A, HTR7 |
4.2593 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, TNKS, TNKS2, TYR, XDH |
4.01486 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.96429 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
3.93127 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.85001 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
3.72978 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR2A, HTR7, OPRM1 |
3.46772 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.4459 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.41562 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.33376 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.30417 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.28868 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, AXL, DRD1, DRD2, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.26092 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, AXL, DRD1, DRD2, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.26092 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC |
3.13574 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B2, HSD17B1, SRC, XDH |
3.11876 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR7 |
3.05949 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR7 |
3.05949 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.98307 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC |
2.9733 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR7, OPRM1 |
2.93604 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.82411 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.82411 |
[MF] GO:0004119 |
None
|
PDE3A, PDE3B |
2.82411 |
[MF] GO:0047555 |
None
|
PDE10A, PDE3A, PDE3B |
2.76721 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
2.73978 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.72989 |
[MF] GO:0004115 |
None
|
PDE10A, PDE3A, PDE3B |
2.69111 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB |
2.57046 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.57046 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR7 |
2.48745 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.45115 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.44605 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR2A, HTR7 |
2.37644 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.33627 |
[MF] GO:0042923 |
None
|
OPRD1, OPRK1, OPRM1 |
2.29437 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.24181 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.23545 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR7 |
2.23335 |
[MF] GO:0004114 |
None
|
PDE10A, PDE3A, PDE3B |
2.23335 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR7 |
2.23335 |
[MF] GO:0004112 |
None
|
PDE10A, PDE3A, PDE3B |
2.18701 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.0814 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, CSNK2A1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PIM1, PTPN1, SRC |
2.07552 |